Drug Patents owned by Recro Gainesville

1. List of Zohydro Er drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339499 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US10456393 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US10722511 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US10322120 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9326982 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9265760 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9610286 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9333201 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9421200 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US10028946 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9433619 RECRO GAINESVILLE Treating pain in patients with hepatic impairment
Jul, 2033

(10 years from now)

US9132096 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(11 years from now)

US9486451 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(11 years from now)

US9713611 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(11 years from now)

US10092559 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(11 years from now)

US9452163 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions
Sep, 2034

(11 years from now)

Drugs and Companies using HYDROCODONE BITARTRATE ingredient

Market Authorisation Date: 25 October, 2013

Treatment: Treatment of pain in patients with hepatic impairment; Treatment of pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of ZOHYDRO ER before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in